Acute effects of candesartan cilexetil (the new angiotensin II antagonist) on systemic and renal haemodynamics in hypertensive patients

European Journal of Clinical Pharmacology

Volumn 54, Issue 7, 1998, Pages 497-501

  Fridman, K ^a   Andersson, O K ^a   Wysocki, M ^a   Friberg, P ^b   Sunzel, M ^c  

^a Department of Internal Medicine ^*  (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c Clinical Pharmacology   (Sweden)

Author keywords

Candesartan cilexetil; Hypertension

Indexed keywords

ANGIOTENSIN; CANDESARTAN HEXETIL; RENIN;

ADULT; AGED; ANGIOTENSIN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; ESSENTIAL HYPERTENSION; FEMALE; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HUMAN; HYPERTENSION; KIDNEY PLASMA FLOW; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; VASCULAR RESISTANCE; VASODILATATION;

ACUTE-PHASE REACTION; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BIPHENYL COMPOUNDS; BLOOD PRESSURE; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; PRODRUGS; RECEPTORS, ANGIOTENSIN; RENAL CIRCULATION; RENIN; TETRAZOLES; VASODILATION;

EID: 0031765650     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050503     Document Type: Article

References (16)

1. Folkow B (1993) The pathophysiology of hypertension. Drugs 46 [Suppl 2]: 3-7
2. Cody RJ (1994) The clinical potential of renin inhibitors and angiotensin II receptor antagonists. Drugs 47: 586-598
3. Oijma M, Inada Y, Shibouta Y, et al (1997) Candesartan (CV-11974) dissociates slowly from the angiotensin A1-receptor. Eur J Clin Pharmacol 319: 137-146
4. Nishikawa K, Naka T, Chatani F, et al (1997) Candesartan cilexetil: a review of its preclinical pharmacology. J Hum Hyp 11[Suppl 2]: S9-S17
5. Heuer HJ, Schöndorfer G, Högemann AM (1997) Twenty-four hour blood pressure profile of different doses of candesartan cilexetil in patients with mild to moderate hypertension. J Hum Hypertens 11 [Suppl 2]: S55-S56
6. Sever P, Holzgreve H (1997) Long-term efficacy and tolerability of candesartan cilexetil in patients with mild to moderate hypertension. J Hum Hypertens 11 [Suppl 2]: S69-S73
7. Elmfeldt D, George M, Hübner R et al (1997) Candesartan cilexetil, a new generation angiotensin II antagonist, provides dose dependent antihypertensive effect. J Hum Hypertens 11 [Suppl 2]: S49-S53
8. Andersson OK, Berglund G, Hausson L et al (1978) Organisation and efficacy of an outpatient clinic. Acta Med Scand 203: 391-398
9. Nilsson NJ (1963) A linearly responding dichromatic cuvette densitometer for dye-dilution curves. Scand J Lab Invest 69 [Suppl]: 181-193
10. Brun C (1951) A rapid method for the determination of paraaminohippuric acid in kidney function tests. J Lab Clin Med 37: 955-958
11. Morton JJ, Webb DJ (1985) Measurement of plasma angiotensin [Letter]. Clin Sci (Colch) 68: 483-484
12. Persson B, Granerous G, Wysocki M et al (1987) Acute systemic and renal haemodynamic effects and long-term antihypertensive action of cadralazine in patients pre-treated with beta-blockers and diuretics. Eur J Clin Pharmacol 31: 513-518
13. Kawabata M, Toshikazu T, Ohta H, et al (1994) Effects of an angiotensin II receptor antagonist, TCV-116, on renal haemodynamics in essential hypertension. Blood Press 3 [Suppl 5]: 117-121
14. Erley CM, Bader B, Scheu M, Wolf S, Braun N, Risler T (1995) Renal hemodynamics in essential hypertensives treated with losartan. Clin Nephrol 43 [Suppl 1]: S8-S11
15. Fauvel JP, Velon S, Berra N, Pozet N, Madonna O, Zech P. Laville M (1996) Effects of losartan on renal function in patients with essential hypertension. J Cardiovasc Pharmacol 28: 259-263
16. Navis GJ, de Zeeuw D, de Jong PE (1986) Enalapril and the kidney: renal vasodilation and natriuresis due to the inhibition of angiotensin II formation. J Cardiovasc Pharmacol 8 [Suppl 1]: S30-34